SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-239441
Filing Date
2021-08-06
Accepted
2021-08-06 17:21:01
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d214812ds3.htm S-3 439066
2 EX-4.9 d214812dex49.htm EX-4.9 279946
3 EX-5.1 d214812dex51.htm EX-5.1 18659
4 EX-5.2 d214812dex52.htm EX-5.2 9061
5 EX-23.1 d214812dex231.htm EX-23.1 1521
6 GRAPHIC g214812g03v73.jpg GRAPHIC 601081
7 GRAPHIC g214812g05a35.jpg GRAPHIC 46630
8 GRAPHIC g214812g80x38.jpg GRAPHIC 597047
9 GRAPHIC g214812snap0002.jpg GRAPHIC 4545
  Complete submission text file 0001193125-21-239441.txt   2449587
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-258598 | Film No.: 211153891
SIC: 3826 Laboratory Analytical Instruments